Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHB1 pseudogene 8 (PHB1P8) is classified as a pseudogene, which denotes a segment of DNA that resembles a gene but is non-functional; pseudogenes typically arise from duplication or retrotransposition events and do not encode functional proteins. There is no evidence in current scientific literature that PHB1P8 encodes a protein or participates in biological pathways, disease processes, or drug interactions. Its designation as “pseudogene 8” signifies it is one in a series of noncoding genetic elements related to the functional prohibitin 1 (PHB1) gene. Unlike protein-coding genes, pseudogenes are usually not considered therapeutic targets, biomarkers, or candidates for direct pharmacologic intervention. As of this writing, there are no reports of PHB1P8 functioning as a protein or having a recognized role in disease, cell biology, or therapy development. PHB1P8 appears to be a computationally annotated pseudogene without a recognized protein or receptor product, without experimental validation, and is not cited as a drug target or biomarker in therapeutic research. This makes it an "incorrect" target from a drug discovery or molecular pharmacology perspective.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHB1 pseudogene 8 (PHB1P8).